Gene · 11126
Papers2,063
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,063
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SLFN11: a pan-cancer biomarker for DNA-targeted drugs sensitivity and therapeutic strategy guidance. | Front Oncol | 2025 | 40766331 | PubTator, text mining | PubMed |
| High-dimensional single-cell phenotyping unveils persistent differences in immune cell profiles between severe and moderate seasonal influenza. | Front Immunol | 2025 | 40766325 | PubTator, text mining | PubMed |
| Targeted RNA sequencing identified gene expression profiles linked to severe necrosis and mortality in preterm infants with surgical necrotizing enterocolitis. | Res Sq | 2025 | 40766230 | PubTator, text mining | PubMed |
| Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications. | Front Immunol | 2025 | 40761786 | PubTator, text mining | PubMed |
| Identification of novel molecular subtypes and construction of a prognostic signature via multi-omics analysis and machine learning in lung adenocarcinoma. | Front Oncol | 2025 | 40761262 | PubTator, text mining | PubMed |
| Heparan sulfate binding protein treatment ameliorates neuropathology and behavioral abnormalities in mucopolysaccharidosis IIIB mice. | Cell Death Discov | 2025 | 40750785 | PubTator, text mining | PubMed |
| Characterization of novel anoikis-related genes as prognostic biomarkers and key determinants of the immune microenvironment in esophageal cancer. | Front Immunol | 2025 | 40746552 | PubTator, text mining | PubMed |
| Integrative network pharmacology and multi-omics reveal anisodamine hydrobromide's multi-target mechanisms in sepsis. | Sci Rep | 2025 | 40744980 | PubTator, text mining | PubMed |
| Gene expression analysis of patients with chronic myeloid leukemia who discontinued tyrosine kinase inhibitor. | Ann Hematol | 2025 | 40742409 | PubTator, text mining | PubMed |
| VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and function. | Cancer Immunol Immunother | 2025 | 40736709 | PubTator, text mining | PubMed |
| Differential Role of CD318 in Tumor Immunity Affecting Prognosis in Colorectal Cancer Compared to Other Adenocarcinomas. | J Clin Med | 2025 | 40725832 | PubTator, text mining | PubMed |
| Aberrant Expression of BTLA, CD160, SPN, TIM-3, VISTA and TIGIT in Chronic Lymphocytic Leukemia and Psoriasis Patients Compared to Healthy Volunteers. | Cancers (Basel) | 2025 | 40647414 | PubTator, text mining | PubMed |
| Altered dynamics of T cell subsets in peripheral blood impacts disease progression in newly diagnosed multiple myeloma. | Biochem Biophys Rep | 2025 | 40641743 | PubTator, text mining | PubMed |
| A novel, rapid, and practical prognostic model for sepsis patients based on dysregulated immune cell lactylation. | Front Immunol | 2025 | 40612938 | PubTator, text mining | PubMed |
| Targeting B and T lymphocyte attenuator in cancer immunotherapy. | Int J Biol Macromol | 2025 | 40480574 | PubTator, text mining | PubMed |
| Application of imaging mass cytometry for spatially profiling the microenvironment of salivary glands in primary Sjögren's syndrome. | Cell Death Dis | 2025 | 40379615 | PubTator, text mining | PubMed |
| Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study. | Nat Commun | 2025 | 40374689 | PubTator, text mining | PubMed |
| [Retracted] lncRNA‑CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infection. | Oncol Lett | 2025 | 40370649 | PubTator, text mining | PubMed |
| In vivo RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancer. | Front Immunol | 2025 | 40352930 | PubTator, text mining | PubMed |
| Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients. | Int J Mol Sci | 2025 | 40243455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11126/papers?page=5